Table 3.
Comparison of peripheral blood values before and after treatment in patients with CC
| XELOX | XELOX + FZSBD | |||
|---|---|---|---|---|
|
|
|
|||
| Pre-treatment | Post-treatment | Pre-treatment | Post-treatment | |
| WBCs (109/L) | 4.26 ± 0.46 | 3.18 ± 0.24*** | 4.30 ± 0.22 | 3.13 ± 0.76*** |
| HB (g/L) | 123.68 ± 44.32 | 98.41 ± 41.19 | 122.39 ± 57.71 | 103.45 ± 56.12 |
| RBCs (1012/L) | 4.91 ± 0.87 | 3.81 ± 0.36*** | 4.88 ± 0.71 | 4.01 ± 054** |
| PLTs (109/L) | 205.68 ± 68.69 | 153.16 ± 61.33** | 208.01 ± 64.49 | 161.11 ± 60.35** |
Notes: n = 23 each group. Data are shown as mean ± SD. The Student’s t-test and Tukey’s test were applied for comparison between groups.
***
P<0.001 vs. the pre-treatment group;
**
P<0.01 vs. the pre-treatment group.
WBCs, white blood cells; RBCs, red blood cells; PLTs, platelets; HB, hemoglobin.